SleepWell Trade

Trend-Following Backtester · Guide · backtest 한국어

equity · US

SAB Biotherapeutics, Inc. backtest

10 trend-following strategies were compared on the full daily history of SAB Biotherapeutics, Inc.. 9 beat buy-and-hold CAGR; ADX / DI 방향성 ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is Keltner 채널 돌파 (CAGR -0.8%, MDD -30.5%).

Data 2021-02-09 ~ 2026-07-31daily bars 1,375 (5.5 years)Costs 0.5%Venue XNASMonthly snapshot 2026-07-31

Results by strategy

9 of 10 beat buy and hold (CAGR -45.8%, drawdown -99.0%).

Sharpe leader (same as main): ADX / DI 방향성 — CAGR 7.6%, MDD -46.6%, Sharpe 0.38, 14% exposure.

Return/drawdown alternative: Keltner 채널 돌파 — CAGR is 53.4%p higher than buy and hold, while drawdown improves by 52.4%p (CAGR -0.8%, MDD -30.5%, exposure 1%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
ADX / DI 방향성
period=30, threshold=29
7.6%-46.6%0.380.161.5x614%
ROC 모멘텀
n=135, threshold=0.08
-4.2%-63.5%0.20-0.070.8x4022%
Donchian 채널 돌파
entryN=21, exitN=40
-16.1%-79.7%0.10-0.200.4x1448%
Keltner 채널 돌파
emaPeriod=7, atrPeriod=9, mult=2.6
-0.8%-30.5%0.05-0.031.0x61%
SMA 크로스오버
fast=45, slow=89
-15.3%-83.5%0.04-0.180.4x1236%
EMA 크로스오버
fast=33, slow=47
-18.4%-83.6%-0.04-0.220.3x2037%
Supertrend
period=8, mult=1.9
-22.6%-86.3%-0.04-0.260.2x4842%
볼린저 밴드 돌파
n=41, k=2
-18.4%-70.6%-0.21-0.260.3x2821%
Parabolic SAR
step=0.015, maxStep=0.12
-27.8%-87.7%-0.22-0.320.2x7839%
MACD
fast=12, slow=56, signal=17
-49.0%-97.5%-0.56-0.500.0x7452%
Buy and hold-45.8%-99.0%-0.07-0.460.0x1100%
0.1 1x 2022 2023 2024 2025 2026 ADX / DI 방향성Buy and hold
ADX / DI 방향성: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -25% -50% -74% -99% 2022 2023 2024 2025 2026 Buy and holdADX / DI 방향성
ADX / DI 방향성 maximum drawdown -46.6% (2021-12-01 → 2023-06-26), recovered after 1,442 days.

Rules of the top strategy

Looks at both the direction and the strength of the trend; holds only in a strong uptrend.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupMore US assetsAll asset reports

Read next